Optimizing therapy of seizures in women who use oral contraceptives

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Harden, Cynthia L ^a,c   Leppik, Ilo ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOCHROME P450 3A4; ESTROGEN; ETHINYLESTRADIOL; ETIRACETAM; FELBAMATE; GABAPENTIN; GESTAGEN; GESTODENE; LAMOTRIGINE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG USE; ENZYME INDUCTION; EPILEPSY; HORMONE METABOLISM; HUMAN; LOW DRUG DOSE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 33845706134     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s56     Document Type: Review

References (15)

1. Physician's Desk Reference 2005. Prescribing information for Ortho Tri-cyclen® Lo Tablets. Montvale, NJ: Thomson PDR.
2. Trussel J. Contraceptive failure in the United States. Contraception 2004;70:89-96.
3. Coulam CB, Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979;20:519-525.
4. Back DJ, Bates M, Bowden A, et al. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception 1980;22:495-503.
5. Crawford P, Chadwick, DJ, Martin C, et al. The interaction of phenytoin and carbamazepine with combined contraceptive steroids. Br J Clin Pharmacol 1990;30:892-896.
6. Anderson GD. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 2004;63(suppl 4):S3-8.
7. Saano V, Manfield CR, Reidenberg P, et al. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive. Clin Pharmacol Ther 1995;58:523-531.
8. Rosenfeld WE, Doose DR, Walker SA, Nayak RK. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997;38:317-323.
9. Doose DR, Wang SS, Padmanabhan M, Schwabe S, Jacobs D, Bialer M. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and non-obese female subjects. Epilepsia 2003;44:540-549.
10. Fattore C, Cipolla G, Gatti G, et al. Induction of ethinyl estradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. Epilepsia 1999;40:783-787.
11. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002;16:263-272.
12. Sabers A, Ohman I, Christensens J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003;61:570-571.
13. Reimers A, Helde G, Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentration. Epilepsia 2005;46:1414-1417.
14. Sidhu J, Bulsara S, Job S, et al. A bidirectional pharmacokinetic interaction study of lamotrigine and the combined oral contraceptive pill in healthy subjects. Epilepsia 2004;45(suppl 7):330. Abstract.
15. Cunnington M; Tennis P. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-960.